{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:41:50Z","timestamp":1790991710907,"version":"4.1.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To describe ophthalmic manifestations of systemic amyloidosis, a group of devastating conditions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A retrospective chart review including patients who had ocular examinations at Mayo Clinic between January 1, 1985, and April 1, 2014, and a diagnosis of light-chain (AL), secondary (AA), or nontransthyretin familial amyloidosis was undertaken. Sixty-eight patients with AL amyloidosis, eight patients with AA amyloidosis, and five patients with nontransthyretin familial amyloidosis were included.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Of 68 patients, 8 patients (14 eyes) with AL amyloidosis had ocular involvement secondary to conjunctiva, temporal artery, extraocular muscle, trabecular meshwork, and cranial nerve deposition. One of the five patients with nontransthyretin familial amyloidosis had gelsolin-related corneal dystrophy. No patients with AA amyloidosis (n = 8) had ophthalmic manifestations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Systemic amyloidosis can lead to ocular morbidity. Patients with AL amyloidosis had involvement of the temporal artery, conjunctiva, extraocular muscles, trabecular meshwork, and cranial nerves. Those with gelsolin nontransthyretin familial amyloidosis were susceptible to corneal dystrophy. Patients with AA amyloidosis did not manifest ophthalmic involvement. Finally, if ocular amyloidosis is detected, patients should be referred for systemic workup.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000001901","type":"journal-article","created":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T18:18:40Z","timestamp":1508869120000},"page":"1371-1376","source":"Crossref","is-referenced-by-count":42,"title":["OCULAR MANIFESTATIONS OF SYSTEMIC AMYLOIDOSIS"],"prefix":"10.1097","volume":"38","author":[{"given":"Margaret M.","family":"Reynolds","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin K.","family":"Veverka","sequence":"additional","affiliation":[{"name":"Mayo Medical School, Mayo Clinic, Rochester, Minnesota;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morie A.","family":"Gertz","sequence":"additional","affiliation":[{"name":"Department of Hematology, Mayo Clinic, Rochester, Minnesota; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Dispenzieri","sequence":"additional","affiliation":[{"name":"Department of Hematology, Mayo Clinic, Rochester, Minnesota; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Zeldenrust","sequence":"additional","affiliation":[{"name":"Department of Hematology, Mayo Clinic, Rochester, Minnesota; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Leung","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose S.","family":"Pulido","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230816","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ajh.23400","article-title":"Immunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatment","volume":"88","author":"Gertz","year":"2013","journal-title":"Am J Hematol"},{"key":"R2-20230816","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","article-title":"Natural history and outcome in systemic AA amyloidosis","volume":"356","author":"Lachmann","year":"2007","journal-title":"N Engl J Med"},{"key":"R3-20230816","first-page":"39","article-title":"Amyloid ophthalmoplegia. Ophthalmoparesis secondary to primary systemic amyloidosis","volume":"9","author":"Katz","year":"1989","journal-title":"J Clin Neuroophthalmol"},{"key":"R4-20230816","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0002-9394(81)90775-3","article-title":"Complete ophthalmoplegia secondary to amyloidosis associated with multiple myeloma","volume":"92","author":"Raflo","year":"1981","journal-title":"Am J Ophthalmol"},{"key":"R5-20230816","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/09273970701505914","article-title":"External ophthalmoplegia as the presenting feature of systemic amyloidosis","volume":"15","author":"Lett","year":"2007","journal-title":"Strabismus"},{"key":"R6-20230816","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/archopht.1968.03850040184015","article-title":"External ophthalmoplegia secondary to systemic amyloidosis","volume":"79","author":"Macoul","year":"1968","journal-title":"Arch Ophthalmol"},{"key":"R7-20230816","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1471-2415-13-82","article-title":"Light-chain amyloidosis mimicking giant cell arteritis in a bilateral anterior ischemic optic neuropathy case","volume":"13","author":"Neri","year":"2013","journal-title":"BMC Ophthalmol"},{"key":"R8-20230816","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jbspin.2011.09.007","article-title":"AL amyloidosis with temporal artery involvement simulates giant-cell arteritis","volume":"79","author":"Audemard","year":"2012","journal-title":"Joint Bone Spine"},{"key":"R9-20230816","first-page":"2283","article-title":"Jaw claudication in primary amyloidosis: unusual presentation of a rare disease","volume":"30","author":"Churchill","year":"2003","journal-title":"J Rheumatol"},{"key":"R10-20230816","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1172\/JCI108690","article-title":"Factors controlling gastric-glucagon release","volume":"59","author":"Lefebvre","year":"1977","journal-title":"J Clin Invest"},{"key":"R11-20230816","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1001\/jamaophthalmol.2013.1618","article-title":"Amyloid deposits in temporal artery mimicking temporal arteritis in a patient with multiple myeloma","volume":"131","author":"Azari","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"R12-20230816","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00005792-198605000-00005","article-title":"Jaw claudication in primary systemic amyloidosis","volume":"65","author":"Gertz","year":"1986","journal-title":"Medicine (Baltimore)"},{"key":"R13-20230816","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1346-8138.1992.tb03191.x","article-title":"Primary systemic amyloidosis: a unique case complaining of diffuse eyelid swelling and conjunctival involvement","volume":"19","author":"Iijima","year":"1992","journal-title":"J Dermatol"},{"key":"R14-20230816","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/bjo.81.4.295","article-title":"Ocular manifestations of familial amyloidotic polyneuropathy type I: long-term follow up","volume":"81","author":"Ando","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"R15-20230816","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0039-6257(95)80025-5","article-title":"Ocular amyloidosis, with special reference to the hereditary forms with vitreous involvement","volume":"40","author":"Sandgren","year":"1995","journal-title":"Surv Ophthalmol"},{"key":"R16-20230816","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/13506129.2012.674076","article-title":"Familial amyloidotic polyneuropathy type IV\u2013gelsolin amyloidosis","volume":"19","author":"Pihlamaa","year":"2012","journal-title":"Amyloid"},{"key":"R17-20230816","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3324\/haematol.2009.008912","article-title":"Current treatment of AL amyloidosis","volume":"94","author":"Palladini","year":"2009","journal-title":"Haematologica"},{"key":"R18-20230816","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0002-9394(00)00567-5","article-title":"Systemic amyloidosis presenting as a mass of the conjunctival semilunar fold","volume":"130","author":"Shields","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"R19-20230816","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.survophthal.2006.04.007","article-title":"Conjunctival amyloidosis: report of six cases and review of the literature","volume":"51","author":"Demirci","year":"2006","journal-title":"Surv Ophthalmol"},{"key":"R20-20230816","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/ICB.0000000000000215","article-title":"Multimodal imaging of the retina and choroid in systemic amyloidosis","volume":"9","author":"Roybal","year":"2015","journal-title":"Retin Cases Brief Rep"},{"key":"R21-20230816","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0002-9394(00)00506-7","article-title":"Chorioretinal involvement in primary systemic nonfamilial amyloidosis","volume":"130","author":"Pece","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"R22-20230816","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3109\/13506129.2012.723074","article-title":"A new lysozyme tyr54asn mutation causing amyloidosis in a family of Swedish ancestry with gastrointestinal symptoms","volume":"19","author":"Girnius","year":"2012","journal-title":"Amyloid"},{"key":"R23-20230816","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1056\/NEJMoa1201356","article-title":"Hereditary systemic amyloidosis due to Asp76Asn variant beta2-microglobulin","volume":"366","author":"Valleix","year":"2012","journal-title":"N Engl J Med"},{"key":"R24-20230816","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/ng1092-157","article-title":"Gelsolin-derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187","volume":"2","author":"de la Chapelle","year":"1992","journal-title":"Nat Genet"},{"key":"R25-20230816","first-page":"634","article-title":"Corneal morphology and sensitivity in lattice dystrophy type II (familial amyloidosis, Finnish type)","volume":"42","author":"Rosenberg","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006982-201807000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:15:22Z","timestamp":1692231322000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-201807000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000001901","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]}}}